Cargando…

Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma

BACKGROUND: Cancer cell repopulation during chemotherapy or radiotherapy is a major factor limiting the efficacy of treatment. Cancer stem cells (CSC) may play critical roles during this process. We aim to demonstrate the role of mesothelioma stem cells (MSC) in treatment failure and eventually to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Licun, Blum, Walter, Zhu, Chang-Qi, Yun, Zhihong, Pecze, Laszlo, Kohno, Mikihiro, Chan, Mei-Lin, Zhao, Yidan, Felley-Bosco, Emanuela, Schwaller, Beat, de Perrot, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921988/
https://www.ncbi.nlm.nih.gov/pubmed/29699510
http://dx.doi.org/10.1186/s12885-018-4354-1
_version_ 1783318121931603968
author Wu, Licun
Blum, Walter
Zhu, Chang-Qi
Yun, Zhihong
Pecze, Laszlo
Kohno, Mikihiro
Chan, Mei-Lin
Zhao, Yidan
Felley-Bosco, Emanuela
Schwaller, Beat
de Perrot, Marc
author_facet Wu, Licun
Blum, Walter
Zhu, Chang-Qi
Yun, Zhihong
Pecze, Laszlo
Kohno, Mikihiro
Chan, Mei-Lin
Zhao, Yidan
Felley-Bosco, Emanuela
Schwaller, Beat
de Perrot, Marc
author_sort Wu, Licun
collection PubMed
description BACKGROUND: Cancer cell repopulation during chemotherapy or radiotherapy is a major factor limiting the efficacy of treatment. Cancer stem cells (CSC) may play critical roles during this process. We aim to demonstrate the role of mesothelioma stem cells (MSC) in treatment failure and eventually to design specific target therapies against MSC to improve the efficacy of treatment in malignant mesothelioma. METHODS: Murine mesothelioma AB12 and RN5 cells were used to compare tumorigenicity in mice. The expression of CSC-associated genes was evaluated by quantitative real-time PCR in both cell lines treated with chemo-radiation. Stemness properties of MSC-enriched RN5-EOS-Puro2 cells were characterized with flow cytometry and immunostaining. A MSC-specific gene profile was screened by microarray assay and confirmed thereafter. Gene Ontology analysis of the selected genes was performed by GOMiner. RESULTS: Tumor growth delay of murine mesothelioma AB12 cells was achieved after each cycle of cisplatin treatment, however, tumors grew back rapidly due to cancer cell repopulation between courses of chemotherapy. Strikingly, a 10-times lower number of irradiated cells in both cell lines led to a similar tumor incidence and growth rate as with untreated cells. The expression of CSC-associated genes such as CD24, CD133, CD90 and uPAR was dramatically up-regulated, while others did not change significantly after chemoradiation. Highly enriched MSC after selection with puromycin displayed an increasing GFP-positive population and showed typical properties of stemness. Comparatively, the proportion of MSC significantly increased after RN5-EOS parental cells were treated with either chemotherapy, γ-ray radiation, or a combination of the two, while MSC showed more resistance to the above treatments. A group of identified genes are most likely MSC-specific, and major pathways related to regulation of cell growth or apoptosis are involved. Upregulation of the gene transcripts Tnfsf18, Serpinb9b, Ly6a, and Nppb were confirmed. CONCLUSION: Putative MSC possess the property of stemness showing more resistance to chemoradiation, suggesting that MSC may play critical roles in cancer cell repopulation. Further identification of selected genes may be used to design novel target therapies against MSC, so as to eliminate cancer cell repopulation in mesothelioma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4354-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5921988
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59219882018-05-01 Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma Wu, Licun Blum, Walter Zhu, Chang-Qi Yun, Zhihong Pecze, Laszlo Kohno, Mikihiro Chan, Mei-Lin Zhao, Yidan Felley-Bosco, Emanuela Schwaller, Beat de Perrot, Marc BMC Cancer Research Article BACKGROUND: Cancer cell repopulation during chemotherapy or radiotherapy is a major factor limiting the efficacy of treatment. Cancer stem cells (CSC) may play critical roles during this process. We aim to demonstrate the role of mesothelioma stem cells (MSC) in treatment failure and eventually to design specific target therapies against MSC to improve the efficacy of treatment in malignant mesothelioma. METHODS: Murine mesothelioma AB12 and RN5 cells were used to compare tumorigenicity in mice. The expression of CSC-associated genes was evaluated by quantitative real-time PCR in both cell lines treated with chemo-radiation. Stemness properties of MSC-enriched RN5-EOS-Puro2 cells were characterized with flow cytometry and immunostaining. A MSC-specific gene profile was screened by microarray assay and confirmed thereafter. Gene Ontology analysis of the selected genes was performed by GOMiner. RESULTS: Tumor growth delay of murine mesothelioma AB12 cells was achieved after each cycle of cisplatin treatment, however, tumors grew back rapidly due to cancer cell repopulation between courses of chemotherapy. Strikingly, a 10-times lower number of irradiated cells in both cell lines led to a similar tumor incidence and growth rate as with untreated cells. The expression of CSC-associated genes such as CD24, CD133, CD90 and uPAR was dramatically up-regulated, while others did not change significantly after chemoradiation. Highly enriched MSC after selection with puromycin displayed an increasing GFP-positive population and showed typical properties of stemness. Comparatively, the proportion of MSC significantly increased after RN5-EOS parental cells were treated with either chemotherapy, γ-ray radiation, or a combination of the two, while MSC showed more resistance to the above treatments. A group of identified genes are most likely MSC-specific, and major pathways related to regulation of cell growth or apoptosis are involved. Upregulation of the gene transcripts Tnfsf18, Serpinb9b, Ly6a, and Nppb were confirmed. CONCLUSION: Putative MSC possess the property of stemness showing more resistance to chemoradiation, suggesting that MSC may play critical roles in cancer cell repopulation. Further identification of selected genes may be used to design novel target therapies against MSC, so as to eliminate cancer cell repopulation in mesothelioma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4354-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-27 /pmc/articles/PMC5921988/ /pubmed/29699510 http://dx.doi.org/10.1186/s12885-018-4354-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wu, Licun
Blum, Walter
Zhu, Chang-Qi
Yun, Zhihong
Pecze, Laszlo
Kohno, Mikihiro
Chan, Mei-Lin
Zhao, Yidan
Felley-Bosco, Emanuela
Schwaller, Beat
de Perrot, Marc
Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma
title Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma
title_full Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma
title_fullStr Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma
title_full_unstemmed Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma
title_short Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma
title_sort putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921988/
https://www.ncbi.nlm.nih.gov/pubmed/29699510
http://dx.doi.org/10.1186/s12885-018-4354-1
work_keys_str_mv AT wulicun putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma
AT blumwalter putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma
AT zhuchangqi putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma
AT yunzhihong putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma
AT peczelaszlo putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma
AT kohnomikihiro putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma
AT chanmeilin putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma
AT zhaoyidan putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma
AT felleyboscoemanuela putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma
AT schwallerbeat putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma
AT deperrotmarc putativecancerstemcellsmaybethekeytargettoinhibitcancercellrepopulationbetweentheintervalsofchemoradiationinmurinemesothelioma